Yakult Honsha Co., Ltd: Pharmaceuticals and Healthcare Company Profile, SWOT & Financial ReportiCD ResearchFebruary 6, 2012 41 Pages - SKU: ICDR6792966 |
| Synopsis ICD Research's Yakult Honsha Co., Ltd: Pharmaceuticals and Healthcare Company Profile, SWOT & Financial Report contains in depth information and data about the company and its operations. The profile contains a company overview, business description, competitive benchmarking, SWOT analysis, key facts, information on products and services, details of locations and subsidiaries, plus information on key news events affecting the company. Summary ICD Research's Yakult Honsha Co., Ltd: Pharmaceuticals and Healthcare Company Profile, SWOT & Financial Report is a crucial resource for industry executives and anyone looking to access key information about Yakult Honsha Co., Ltd.. ICD Research's Yakult Honsha Co., Ltd: Pharmaceuticals and Healthcare Company Profile, SWOT & Financial Report report utilizes a wide range of primary and secondary sources, which are analyzed and presented in a consistent and easily accessible format. ICD Research strictly follows a standardized research methodology to ensure high levels of data quality and these characteristics guarantee a unique report. Scope
Yakult Honsha Co., Ltd. (Yakult) provides a wide range of probiotic and pharmaceutical products. The company conducts its business operations under three reportable segments, Food and Beverages, Pharmaceuticals and Others. Under Food and Beverages segment, it offers various dairy products, soft drinks, juices and noodles. The company, through its Food and Beverages segment, manufactures probiotic products. Its pharmaceutical segment is focused on the manufacture and sale of anti-cancer products. The company sells its pharmaceutical products to pharmacies and hospitals through wholesalers. In addition, it offers cosmetics products to its customers. The company operates in South America, North America, Europe, Asia and Oceania. As of March 31, 2011, It had about 81 subsidiaries, 16 associated companies and an affiliated company. Yakult is headquartered in Tokyo, Japan. |
Related Markets
Pharmaceuticals Company Reports
- Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals - Q1 2012
- Co-promotion and Co-marketing Partnering Terms and Agreements in Pharma, Biotech and Diagnostics
- Royalty Financing Terms and Agreements in Pharma, Biotech and Diagnostics
- Partnerships, Licensing, Investments and M&A Deals and Trends for March 2012 in Pharmaceuticals
- Contract Research Organizations (CROs) Market to 2018 - Public-Private Partnerships to Strengthen Research Capacities and Advance Clinical Development Programs

